|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Ethylene chlorohydrin | CAS 107-07-3 | ||
| CH2ClCH2OH | RTECS KK0875000 | ||
|
Synonyms & Trade Names 2-Chloroethanol, 2-Chloroethyl alcohol, Ethylene chlorhydrin |
DOT ID & Guide 1135 131 |
||
|
Exposure Limits |
NIOSH REL: C 1 ppm (3 mg/m3) [skin] | ||
| OSHA PEL�: TWA 5 ppm (16 mg/m3) [skin] | |||
| IDLH 7 ppm | Conversion 1 ppm = 3.29 mg/m3 | ||
|
Physical Description Colorless liquid with a faint, ether-like odor. |
|||
|
MW: 80.5 |
BP: 262°F |
FRZ: -90°F |
Sol: Miscible |
|
VP: 5 mmHg |
IP: 10.90 eV |
|
Sp.Gr: 1.20 |
|
Fl.P: 140°F |
UEL: 15.9% |
LEL: 4.9% |
|
| Class IIIA Combustible Liquid: Fl.P. at or above 140�F and below 200�F. | |||
|
Incompatibilities & Reactivities Strong oxidizers, strong caustics, water or steam |
|||
|
Measurement Methods NIOSH 2513; OSHA 7 |
|
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet or contaminated Change: No recommendation Provide: Eyewash, Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Water flush immediately Breathing: Respiratory support Swallow: Medical attention immediately |
|
Respirator Recommendations
NIOSH Up to 7 ppm: (APF = 10) Any supplied-air respirator*/(APF = 50) Any self-contained breathing apparatus with a full facepiece Emergency or planned entry into unknown concentrations or IDLH conditions: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode/(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister/Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms Irritation mucous membrane; nausea, vomiting; dizziness, incoordination; numbness; visual disturbance; headache; thirst; delirium; low blood pressure; collapse, shock, coma; liver, kidney damage | |
|
Target Organs
respiratory system, liver, kidneys, central nervous system, cardiovascular system, eyes |
|
| See also: INTRODUCTION |